The Department of Medicine Welcomes Three Experts to the Division of Infectious Diseases
David Calfee, MD, MS serves as the new Chief Hospital Epidemiologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He earned his medical degree from West Virginia University School of Medicine in Morgantown and completed an internship and residency in internal medicine and a fellowship in infectious diseases at the University of Virginia. He also received a master of science degree in health evaluation sciences from the University of Virginia. After completing fellowship training, he served on the faculty of the University of Virginia School of Medicine. In 2003, he relocated to New York City to become the Hospital Epidemiologist and Infection Control Officer for The Mount Sinai Hospital, where he was an Associate Professor of Medicine in the Division of Infectious Diseases. His research interests include the epidemiology and prevention of healthcare-associated infections and antibiotic resistance.
Stephen J. Wilson, MD, MPH serves as a new Hospital Epidemiologist and is looking forward to working with Dr. Dave Calfee to build a robust academic hospital epidemiology program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Wilson received his medical degree from Duke University School of Medicine and an MPH in epidemiology from the University of North Carolina School of Public Health, and completed clinical infectious diseases training at the University of California, San Francisco, Medical Center. He has held faculty positions at Duke University School of Medicine and Indiana University School of Medicine where he was a hospital epidemiologist for nine years. He has conducted epidemiologic research on a wide variety of infection control issues and mentored numerous medical students, residents, and fellows during his time at Indiana University.
After nearly a quarter-century of dedicated public service at the National Cancer Institute (NCI), Thomas Walsh, MD will serve as the new Director of the Transplantation-Oncology Infectious Diseases Program in the Division of Infectious Diseases of the Department of Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Upon graduating from The Johns Hopkins University School of Medicine, he completed 10 years of clinical and laboratory postdoctoral training, leading to board certification in internal medicine, infectious diseases and medical oncology. While serving as Chief of the Immunocompromised Host Section in the Pediatric Oncology Branch of the NCI, Dr. Walsh developed an internationally recognized laboratory and clinical-translational research program dedicated to host defense, molecular detection, and antimicrobial pharmacology of invasive fungal infections in immunocompromised pediatric and adult patients.